PLX038 (PEGylated SN38)

PEGylated SN-38

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PLX038 (PEGylated SN38), covering 2024-01-03 to 2024-01-03. Get the full timeline:

Most recent: Clinical Trial Update: PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers [Phase 1, Phase 2]